5L01 | pdb_00005l01

Tryptophan 5-hydroxylase in complex with inhibitor (3~{S})-8-[2-azanyl-6-[(1~{R})-1-(4-chloranyl-2-phenyl-phenyl)-2,2,2-tris(fluoranyl)ethoxy]pyrimidin-4-yl]-2,8-diazaspiro[4.5]decane-3-carboxylic acid

External Resource: Annotation

Domain Annotation: SCOP2 Classification
Domain Annotation: ECOD Classification
Domain Annotation: CATH
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2B Superfamily	Aromatic aminoacid monoxygenases, catalytic and oligomerization domains	8043675	3001457	SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A		e5l01A1	A: HSP20-like	X: profilin-like	H: C-terminal domain in DHH phosphoesterases	T: Flav_NS3-hel_C	F:	ECOD (20:10:01)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	1.10.800.10	Mainly Alpha	Orthogonal Bundle	Phenylalanine Hydroxylase	Aromatic amino acid hydroxylase	CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF00351	Biopterin-dependent aromatic amino acid hydroxylase (Biopterin_H)	Biopterin-dependent aromatic amino acid hydroxylase	This family includes phenylalanine-4-hydroxylase, the phenylketonuria disease protein.	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	Tryptophan 5-hydroxylase 1	oxidoreductase activity monooxygenase activity tryptophan 5-monooxygenase activity oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen catalytic activity cation binding transition metal ion binding iron ion binding ion binding binding metal ion binding small molecule binding	multicellular organismal process tissue remodeling bone remodeling regulation of body fluid levels regulation of biological process biological regulation hemostasis regulation of biological quality regulation of hemostasis serotonin metabolic process biosynthetic process indole-containing compound biosynthetic process phenol-containing compound metabolic process indole-containing compound metabolic process multicellular organismal process tissue remodeling bone remodeling regulation of body fluid levels regulation of biological process biological regulation hemostasis regulation of biological quality regulation of hemostasis serotonin metabolic process biosynthetic process indole-containing compound biosynthetic process phenol-containing compound metabolic process indole-containing compound metabolic process phenol-containing compound biosynthetic process metabolic process cellular process primary amino compound biosynthetic process serotonin biosynthetic process regulated exocytosis cellular localization transport secretion platelet degranulation export from cell establishment of localization vesicle-mediated transport localization secretion by cell exocytosis establishment of localization in cell aromatic amino acid metabolic process oxoacid metabolic process carboxylic acid metabolic process amino acid metabolic process primary metabolic process organic acid metabolic process alpha-amino acid metabolic process L-amino acid metabolic process proteinogenic amino acid metabolic process L-tryptophan metabolic process serotonin biosynthetic process from L-tryptophan small molecule metabolic process developmental process fat cell differentiation positive regulation of fat cell differentiation regulation of cellular process regulation of developmental process cellular developmental process positive regulation of biological process regulation of cell differentiation positive regulation of developmental process positive regulation of cell differentiation cell differentiation regulation of fat cell differentiation positive regulation of cellular process mammary gland development gland development animal organ development anatomical structure development mammary gland lobule development mammary gland alveolus development	cellular anatomical structure intracellular anatomical structure cytoplasm cytosol cell projection neuron projection plasma membrane bounded cell projection

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR019773	Tyrosine 3-monooxygenase-like	Family
A	IPR019774	Aromatic amino acid hydroxylase, C-terminal	Domain
A	IPR041904	Tryptophan 5-hydroxylase, catalytic domain	Domain
A	IPR045865	ACT-like domain	Homologous Superfamily
A	IPR002912	ACT domain	Domain
A	IPR036329	Aromatic amino acid monoxygenase, C-terminal domain superfamily	Homologous Superfamily
A	IPR005963	Tryptophan 5-monooxygenase	Family
A	IPR036951	Aromatic amino acid hydroxylase superfamily	Homologous Superfamily
A	IPR001273	Aromatic amino acid hydroxylase	Family
A	IPR018301	Aromatic amino acid hydroxylase, iron/copper binding site	Binding Site

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: P17752	schizophrenia pulmonary hypertension Alcoholic Intoxication, Chronic depressive disorder kidney neoplasm lung carcinoma malignant colon neoplasm psoriasis bipolar disorder diarrheal disease large cell medulloblastoma cutaneous lupus erythematosus kidney cancer lung cancer major depressive disorder schizophrenia pulmonary hypertension Alcoholic Intoxication, Chronic depressive disorder kidney neoplasm lung carcinoma malignant colon neoplasm psoriasis bipolar disorder diarrheal disease large cell medulloblastoma cutaneous lupus erythematosus kidney cancer lung cancer major depressive disorder medulloblastoma osteosarcoma

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.